Status:
COMPLETED
Heparin and the Reduction of Thrombosis (HART) Trial
Lead Sponsor:
Stanford University
Conditions:
Thrombosis
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of...
Detailed Description
Patients are contacted pre-operatively and their parents consented. The following criteria apply: Inclusion criteria: All infants \< 1 year of age undergoing cardiac surgery at Lucile Packard Childr...
Eligibility Criteria
Inclusion
- All infants \< 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital \& #xA
Exclusion
- Known coagulopathy
- History of clinically significant bleeding (GI, cranial, pulmonary)
- Need for therapeutic heparinization
- ECMO
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00779558
Start Date
November 1 2005
End Date
November 1 2007
Last Update
June 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305